Psychiatric medication management for Coral Springs — measurement-based, in-person.

For Coral Springs and Parkland patients — from Eagle Trace to Heron Bay — RECO Integrated Psychiatry is 25 miles and about 35 minutes northeast via the Sawgrass Expressway and I-95. The practice runs 60- to 90-minute DSM-5-TR evaluations, PHQ-9 and GAD-7 measurement-based follow-ups, and the full pharmacologic toolkit — augmentation with aripiprazole or lithium, cross-class switching, selective pharmacogenomic testing, and in-house escalation to Spravato or rTMS when first-line pharmacotherapy is not enough. Follow-ups can be delivered by telepsychiatry once the in-person intake is complete.

Coral Springs sits about 25 miles inland from RECO Integrated Psychiatry’s Delray Beach office — roughly a 35-minute drive northeast via the Sawgrass Expressway and I-95 that puts specialist outpatient psychiatry in reach for families in Eagle Trace, Hidden Hammocks, Parkland Isles, Cypress Run, and Heron Bay. What most local prescribers cannot match is the depth of the pharmacologic toolkit and the discipline of measurement-based follow-up that define the practice. RECO offers psychiatric medication management built for adults who need specialist-level care without the disruption of a residential program.

What a real psychiatric evaluation actually covers

The initial visit runs 60 to 90 minutes and ends in a documented DSM-5-TR diagnostic formulation — not a checklist of symptoms with an SSRI attached. The history covers every prior medication trial in detail: the specific compound, the dose reached, the duration on that dose, and the specific reason it was discontinued, whether that was inefficacy, sexual side effects, weight gain, activation, or GI intolerance. Family psychiatric history is documented across at least two generations, a substance use screen is completed, and trauma history is elicited where clinically indicated.

A presentation of “depression” is screened for bipolarity with the MDQ before an antidepressant is started, because antidepressant monotherapy in undiagnosed bipolar II is one of the more common reasons treatment fails for years. Adult ADHD is screened with the ASRS where attention and executive-function complaints are prominent, and OCD is screened with the Y-BOCS when obsessive-compulsive symptoms surface in history. Baseline labs — CBC, CMP, TSH, B12, folate, and vitamin D — are ordered where results will change management. This is the visit primary care does not have the time or scope to run.

Measurement-based care and why it changes outcomes

PHQ-9 for depression, GAD-7 for anxiety, MDQ for bipolar screening, ASRS for adult ADHD, and Y-BOCS for OCD are completed in the patient portal before each visit, scored during the visit, and tracked longitudinally in the chart. Medication decisions are anchored to the scale trajectory rather than to whether the patient felt better on the day of the appointment. When a PHQ-9 stalls at 14 for eight weeks on sertraline 100 mg, that is a decision point, not a nudge upward.

The published evidence — from the STAR*D sequencing data through more recent randomized comparisons — is clear that measurement-based care produces meaningfully better response and remission rates than clinical impression alone. The scores also carry the treatment conversation with spouses and family members, because a PHQ-9 that has fallen from 21 to 6 is easier to trust than a self-report from a patient with alexithymia or a long history of masking symptoms.

The pharmacologic toolkit beyond the first two SSRIs

First-line pharmacotherapy is not the hard part. SSRIs and SNRIs — sertraline, escitalopram, venlafaxine, duloxetine — cover most mood and anxiety presentations. Stimulants and non-stimulants — methylphenidate, mixed amphetamine salts, atomoxetine, viloxazine — cover ADHD. Mood stabilizers and atypicals — lithium, lamotrigine, quetiapine, aripiprazole, olanzapine — cover bipolar disorder. SSRIs plus a referral for exposure and response prevention cover most OCD. Buspirone remains useful in adjunctive anxiety management.

The value of specialty psychiatry emerges when first-line fails. Augmentation with aripiprazole, lithium, or thyroid hormone is standard for treatment-resistant depression. Switching within class is often less useful than switching across class — an SSRI to bupropion, or to mirtazapine, or to an SNRI. MAOIs are used in the small subset of patients who warrant them. Pharmacogenomic panels such as GeneSight and Genomind are ordered selectively where CYP2D6 or CYP2C19 status will change the choice, not reflexively. When the outpatient algorithm has been worked through appropriately, escalation to esketamine (Spravato) or rTMS is the next step, and RECO delivers both in-house rather than referring out.

Monitoring — labs, metabolic panels, and drug levels

Lithium requires a baseline TSH, creatinine, and calcium, plus a 12-hour post-dose lithium level. Levels and renal function are rechecked quarterly during the first year and at least every six months thereafter. Atypical antipsychotics — olanzapine and quetiapine most notably — require baseline weight, waist circumference, blood pressure, fasting glucose or HbA1c, and a lipid panel, with the metabolic set repeated at three months and annually thereafter. Valproate requires baseline LFTs, CBC with platelets, and valproate levels once dosing is stabilized.

Stimulant prescribing requires a cardiovascular history at intake, documented blood pressure and pulse at every visit, and an EKG where personal or family cardiac risk factors warrant it. Clozapine, when used, follows the REMS ANC monitoring schedule without exception. RECO’s protocol builds these into the visit cadence rather than depending on the patient to remember to ask for them, which is the failure point in a great deal of community prescribing.

What to expect on your first visit from Coral Springs

The intake is scheduled for 90 minutes. Patients complete PHQ-9, GAD-7, MDQ, and ASRS in the portal before arrival so the scoring is done and the psychiatrist can spend the visit on formulation rather than paperwork. Records from prior prescribers and any recent lab work are requested in advance so treatment history is not reconstructed from memory alone.

The visit ends with a written diagnostic impression, a treatment plan that specifies the medication choice and rationale, any labs to be drawn, and a follow-up cadence — typically two to four weeks for a new medication trial, then extending as the scale trajectory stabilizes. For Coral Springs and Parkland families driving in from Heron Bay or Parkland Isles, most follow-ups can be delivered by telepsychiatry once the in-person evaluation and indicated labs are complete, so the 35-minute drive is not required for every check-in.

Insurance and access from Coral Springs

RECO Integrated Psychiatry is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS plans commonly held by Coral Springs and Parkland residents. Benefits are verified before the initial evaluation and the out-of-pocket estimate — remaining deductible, copay, coinsurance — is provided in writing. Cash-pay rates for the initial 60-90 minute evaluation and for standard follow-ups are published so there are no surprises at check-in.

New-patient evaluations are typically available within one to two weeks; urgent presentations are triaged the same day. Scheduling from the west side of Coral Springs — Eagle Trace and Cypress Run — is usually easier in the late morning, which avoids the tightest Sawgrass congestion on the return drive.

Serving residents of: Eagle Trace, Hidden Hammocks, Parkland Isles, Cypress Run, Heron Bay.